欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4067/002
药品名称Lenalidomide Teva 5 mg, harde capsules
活性成分
    • lenalidomide hydrochloride 5.0 mg
剂型Capsule, hard
上市许可持有人Teva B.V. the Netherlands
参考成员国 - 产品名称Netherlands (NL)
Lenalidomide Teva 5 mg, harde capsules
互认成员国 - 产品名称
    • Iceland (IS)
    • Germany (DE)
      Lenalidomid-ratiopharm 5 mg Hartkapseln
    • Denmark (DK)
    • Luxembourg (LU)
      Lenalidomide Teva, 5 mg, Gélule
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Lenalomid TEVA 5 mg Hartkapseln
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Lenalidomide Teva
    • Finland (FI)
    • Hungary (HU)
      LENALIDOMID TEVA 5 mg kemény kapszula
    • Czechia (CZ)
      Lenalidomid Teva
    • Slovakia (SK)
      Lenalidomid Teva B.V. 5 mg
    • Slovenia (SI)
      Lenalidomid Teva 5 mg trde kapsule
    • Croatia (HR)
      Lenalidomid Teva 5 mg tvrde kapsule
许可日期2018/07/12
最近更新日期2024/12/11
药物ATC编码
    • L04AX04 lenalidomide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase